Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases. [electronic resource]
Producer: 20160928Description: 84 p. digitalISSN:- 1471-2407
- Bevacizumab -- administration & dosage
- Camptothecin -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Fluorouracil -- administration & dosage
- Hepatectomy
- Hepatic Veno-Occlusive Disease -- drug therapy
- Humans
- Liver -- drug effects
- Liver Neoplasms -- drug therapy
- Neoadjuvant Therapy -- adverse effects
No physical items for this record
Publication Type: Journal Article; Meta-Analysis
There are no comments on this title.
Log in to your account to post a comment.